Nancy Thomas
Adult Health · Youngstown, OHNPI 1457599367
Payments from drug & device makers
Across 80 payments — averaging $15.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$210
- Novo Nordisk$115
- Sanofi-aventis U.S. LLC$101
- Lilly USA, LLC$94
- Johnson & Johnson$82
- Amgen$80
- plus $531 from 14 others
What the payments were for
- Food & beverage$1,213100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $210 |
| Novo Nordisk | 7 | $115 |
| Sanofi-aventis U.S. LLC | 6 | $101 |
| Lilly USA, LLC | 6 | $94 |
| Johnson & Johnson | 6 | $82 |
| Amgen | 6 | $80 |
| Amarin Pharma, Inc. | 5 | $75 |
| Merck | 4 | $75 |
| Abbott | 3 | $64 |
| Sunovion Pharmaceuticals Inc. | 3 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Pfizer | 3 | $48 |
| Eisai Inc. | 2 | $43 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Novartis | 2 | $25 |
| Boehringer Ingelheim | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Urovant Sciences Inc | 1 | $14 |
| Astellas Pharma US Inc | 1 | $12 |
How this compares
$1,213 in reported general payments places this provider in the 70th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 11 | $244 |
| Valsartan | 11 | $235 |
| Levothyroxine Sodium | 24 | $221 |
| Rosuvastatin Calcium | 22 | $205 |
| Losartan Potassium | 15 | $180 |
| Fluticasone Propionate | 18 | $159 |
| Hydrochlorothiazide | 14 | $108 |
| Atorvastatin Calcium | 19 | $54 |
| Methylprednisolone | 12 | $28 |
Paid to pharmacies, not to this prescriber.
Other adult health in Youngstown
- Jesse McClainYoungstown$79K
- Frances ClarkYoungstown$18K
- Deborah NicholsYoungstown$8K
- Bonnie MohlerCanton$338K
- Andrew GuinigundoCincinnati$215K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
- Susan FlickCleveland$131K
- Margaret TiktinCleveland$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.